152 related articles for article (PubMed ID: 23621407)
1. Multifunctional dendritic sialopolymersomes as potential antiviral agents: their lectin binding and drug release properties.
Nazemi A; Haeryfar SM; Gillies ER
Langmuir; 2013 May; 29(21):6420-8. PubMed ID: 23621407
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles.
Papp I; Sieben C; Ludwig K; Roskamp M; Böttcher C; Schlecht S; Herrmann A; Haag R
Small; 2010 Dec; 6(24):2900-6. PubMed ID: 21104827
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting.
Meng F; Engbers GH; Feijen J
J Control Release; 2005 Jan; 101(1-3):187-98. PubMed ID: 15588904
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-influenza virus evaluation of triterpene-sialic acid conjugates.
Tsuji M; Sriwilaijaroen N; Inoue H; Miki K; Kinoshita K; Koyama K; Furuhata K; Suzuki Y; Takahashi K
Bioorg Med Chem; 2018 Jan; 26(1):17-24. PubMed ID: 29198893
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes.
Egli S; Nussbaumer MG; Balasubramanian V; Chami M; Bruns N; Palivan C; Meier W
J Am Chem Soc; 2011 Mar; 133(12):4476-83. PubMed ID: 21370858
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.
Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem; 2009 Aug; 17(15):5465-75. PubMed ID: 19589684
[TBL] [Abstract][Full Text] [Related]
7. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.
Sakamoto J; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Esumi Y; Nakamura T; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem; 2009 Aug; 17(15):5451-64. PubMed ID: 19592257
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza virus activity by newly designed multivalent glycoarchitectures.
Papp I; Sieben C; Sisson AL; Herrmann A; Haag R
J Control Release; 2010 Nov; 148(1):e114-5. PubMed ID: 21529585
[No Abstract] [Full Text] [Related]
9. The OAAH Family: Anti-Influenza Virus Lectins.
Sato Y; Hirayama M; Morimoto K; Hori K
Methods Mol Biol; 2020; 2132():683-693. PubMed ID: 32306367
[TBL] [Abstract][Full Text] [Related]
10. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
[TBL] [Abstract][Full Text] [Related]
11. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
12. Screening from the world's largest TCM database against H1N1 virus.
Chang TT; Sun MF; Chen HY; Tsai FJ; Fisher M; Lin JG; Chen CY
J Biomol Struct Dyn; 2011 Apr; 28(5):773-86. PubMed ID: 21294588
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of amphiphilic alternating polyesters with oligo(ethylene glycol) side chains and potential use for sustained release drug delivery.
Wang W; Ding J; Xiao C; Tang Z; Li D; Chen J; Zhuang X; Chen X
Biomacromolecules; 2011 Jul; 12(7):2466-74. PubMed ID: 21649444
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function.
Yanagita H; Yamamoto N; Fuji H; Liu X; Ogata M; Yokota M; Takaku H; Hasegawa H; Odagiri T; Tashiro M; Hoshino T
ACS Chem Biol; 2012 Mar; 7(3):552-62. PubMed ID: 22217114
[TBL] [Abstract][Full Text] [Related]
15. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Bereczki I; Kicsák M; Dobray L; Borbás A; Batta G; Kéki S; Nikodém ÉN; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3251-4. PubMed ID: 24974341
[TBL] [Abstract][Full Text] [Related]
16. Multivalent oleanolic acid human serum albumin conjugate as nonglycosylated neomucin for influenza virus capture and entry inhibition.
Yang Y; He HJ; Chang H; Yu Y; Yang MB; He Y; Fan ZC; Iyer SS; Yu P
Eur J Med Chem; 2018 Jan; 143():1723-1731. PubMed ID: 29146135
[TBL] [Abstract][Full Text] [Related]
17. STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core.
Haselhorst T; Blanchard H; Frank M; Kraschnefski MJ; Kiefel MJ; Szyczew AJ; Dyason JC; Fleming F; Holloway G; Coulson BS; von Itzstein M
Glycobiology; 2007 Jan; 17(1):68-81. PubMed ID: 16973731
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic fabrication of monodisperse biocompatible and biodegradable polymersomes with controlled permeability.
Shum HC; Kim JW; Weitz DA
J Am Chem Soc; 2008 Jul; 130(29):9543-9. PubMed ID: 18576631
[TBL] [Abstract][Full Text] [Related]
19. Binding determinants of the sialic acid-specific lectin from the slug Limax flavus.
Knibbs RN; Osborne SE; Glick GD; Goldstein IJ
J Biol Chem; 1993 Sep; 268(25):18524-31. PubMed ID: 7689555
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
